Home / Inspections / 1021256

FDA Inspection 1021256 — Mark B. Anderson, MD

Mark B. Anderson, MD — FEI 3013526025

The FDA completed an inspection of Mark B. Anderson, MD on Aug 3, 2017 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Aug 3, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Philadelphia, PA (United States)

Additional details

Clinical Investigator (CI)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.